Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Medicinal Chemistry

• Publication date

  2015-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/0929867322666150420124427PMID 25891107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble CD40 ligand is associated with angiographic severity of coronary artery disease in patients with acute coronary syndrome

  2014cited by this paper
• Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

  2014cited by this paper
• Sequential Analysis of Myeloperoxidase for Prediction of Adverse Events After Suspected Acute Coronary Ischemia

  2014cited by this paper
• Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.

  2014cited by this paper
• Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).

  2014cited by this paper
• Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.

  2014cited by this paper
• Prognostic utility of the soluble CD40 ligand in acute coronary syndrome.

  2014cited by this paper
• Infusion of Pharmaceutical-Grade Natural Human C-Reactive Protein Is Not Proinflammatory in Healthy Adult Human Volunteers

  2014cited by this paper
• Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction

  2014cited by this paper
• Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.

  2013cited by this paper
• Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.

  2013cited by this paper
• Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study

  2013cited by this paper
• Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report.

  2013cited by this paper
• Pathogenesis of acute coronary syndromes.

  2013cited by this paper
• The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department

  2013cited by this paper
• Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.

  2012cited by this paper
• Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction.

  2012cited by this paper
• Ischemia-modified albumin (IMA) in differential diagnosis of transient myocardial ischemia from non ischemic chest pain.

  2012cited by this paper
• Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

  2011cited by this paper
• Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms.

  2011cited by this paper
• Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.

  2011cited by this paper
• Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case–control study of older men and women

  2011cited by this paper
• Current role of ischemia-modified albumin in routine clinical practice

  2010cited by this paper
• Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.

  2010cited by this paper
• Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.

  2010cited by this paper
• A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation.

  2009cited by this paper
• Increased ischaemia modified albumin following coronary artery bypass grafting

  2009cited by this paper
• Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations.

  2009cited by this paper
• Ischemia modified albumin: is this marker of ischemia ready for prime time use?

  2008cited by this paper
• The search for new cardiovascular biomarkers

  2008cited by this paper
• Novel biomarkers--the long march from bench to bedside.

  2008cited by this paper
• CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.

  2008cited by this paper
• Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

  2008cited by this paper
• Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.

  2007cited by this paper
• Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.

  2006cited by this paper
• Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events.

  2006cited by this paper
• Pregnancy‐associated plasma protein A: A biomarker in acute ST‐elevation myocardial infarction (STEMI)

  2006cited by this paper
• Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

  2006cited by this paper
• Prognostic value of serum amyloid A protein in patients with acute myocardial infarction.

  2005cited by this paper
• Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

  2005cited by this paper
• Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis

  2005cited by this paper
• C-reactive protein and atherogenesis: new insights from established animal models.

  2005cited by this paper
• Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.

  2005cited by this paper
• GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention

  2005cited by this paper
• Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer

  2004cited by this paper
• Myeloperoxidase and plaque vulnerability.

  2004cited by this paper
• C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice

  2004cited by this paper
• Prognostic value of myeloperoxidase in patients with chest pain.

  2003cited by this paper
• Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

  2003cited by this paper
• Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.

  2003cited by this paper
• Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue

  2003cited by this paper
• The lipid and non-lipid effects of statins.

  2003cited by this paper
• C-reactive protein and other inflammatory risk markers in acute coronary syndromes.

  2003cited by this paper
• Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy

  2003cited by this paper
• Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice

  2003cited by this paper
• Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease

  2003cited by this paper
• Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells

  2003cited by this paper
• Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation

  2003cited by this paper
• Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Inflammation and Long-Term Mortality After Non-ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients

  2002cited by this paper
• Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy

  2002cited by this paper
• Generation of C-reactive protein and complement components in atherosclerotic plaques.

  2001cited by this paper
• Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.

  2001cited by this paper
• Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

  2001cited by this paper
• Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes.

  2000cited by this paper
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.

  2000cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Identification of soluble forms of lectin-like oxidized LDL receptor-1.

  2000cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998cited by this paper
• Insulin-like growth factor binding protein proteolysis

  1997cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper

• Derivation and external validation of mass spectrometry-based proteomic model using machine learning algorithms to predict plaque rupture in patients with acute coronary syndrome.

  2024cites this paper
• Correlation between uric acid/HDL ratio and total calcium score in coronary CT angiography

  2024influential citation
• Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients

  2024cites this paper
• The relationship between the new inflammatory markers and disease severity in patients with acute coronary syndrome

  2024cites this paper
• Elevated systemic inflammation level increases the risk of incident cancer mortality among patients with coronary artery disease.

  2023cites this paper
• The role of decoy receptor 3 in inflammation and atherosclerosis in patients with chronic kidney disease and renal transplant patients.

  2022cites this paper
• Molekulare Biomarker der Atherosklerose

  2022cites this paper
• Discovery of plasma biomarkers with data‐independent acquisition mass spectrometry and antibody microarray for diagnosis and risk stratification of pulmonary embolism

  2021cites this paper
• Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium.

  2021cites this paper
• Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids

  2021cites this paper
• Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial

  2021cites this paper
• Guanxin V for coronary artery disease: A retrospective study.

  2020cites this paper
• The Biochemical Markers Associated with the Occurrence of Coronary Spasm

  2019cites this paper
• Oxidative Stress in Metabolic Syndrome: Experimental Model of Biomarkers

  2019cites this paper
• Correlating Red Cell Distribution Width Parameter with Severity of Coronary Artery Disease

  2019cites this paper
• Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders

  2019cites this paper
• Involvement of Protein-Protein Interactions of eNOS and Genetic Polymorphisms in Coronary Artery Disease

  2018cites this paper
• Increased glycoprotein acetylation is associated with high cardiac event rates: Analysis using coronary computed tomography angiography

  2018cites this paper
• Comparative Effects of Blood and Crystalloid Cardioplegia on Cellular Injury and Oxidative Stress in Cardiovascular Surgery

  2018cites this paper
• Editorial: C-Reactive Protein in Age-Related Disorders

  2018cites this paper
• Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls

  2018cites this paper
• Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development

  2017cites this paper
• Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria

  2017cites this paper
• Toll-like receptor 4 contributes to acute kidney injury after cardiopulmonary resuscitation in mice

  2016cites this paper
• Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?

  2016cites this paper
• Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.

  2015cites this paper